|Mr. Chris A. Raanes||Pres, CEO & Director||622.5k||N/A||1965|
|Mr. Ajay Bansal||CFO & Principal Accounting Officer||295.26k||N/A||1962|
|Dr. James F. Dempsey Ph.D.||Chief Scientific Officer & Director||351k||N/A||1971|
|Mr. Douglas H. Keare||Chief Operating Officer||N/A||N/A||1964|
|Mary E. O'Byrne||VP & Chief Counsel||N/A||N/A||N/A|
ViewRay, Inc., through its subsidiary, ViewRay Technologies, Inc., designs, manufactures, and markets radiation therapy systems. It offers MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient's anatomy simultaneously. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the location and shape of soft-tissue tumors while radiation is delivered. Its customers include university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. The company markets its MRIdian through a direct sales force in the United States, as well as through distributors internationally. ViewRay, Inc. was founded in 2004 and is headquartered in Oakwood Village, Ohio.
ViewRay, Inc.’s ISS Governance QualityScore as of March 1, 2018 is 9. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 8; Compensation: 9.